2,164
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review

, , , , , , , , & show all
Article: 2145970 | Received 08 Jun 2022, Accepted 04 Nov 2022, Published online: 12 Jan 2023

References

  • Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95(5):548–567.
  • Lin ZS, Yu XJ, Zhang X, et al. Monoclonal immunoglobulin-associated renal lesions in patients with newly diagnosed multiple myeloma: a report from a single center. Cancer Manag Res. 2021;13:3879–3888.
  • Fang H, Chiu A, Reichard KK. Crystal-storing histiocytosis in bone marrow: a clinicopathologic study of eight cases and review of the literature. Am J Clin Pathol. 2018;149(2):148–163.
  • Gupta RK, Rosenberg AZ, Bagnasco SM, et al. Renal crystal-storing histiocytosis involving glomeruli - a comprehensive clinicopathologic analysis. Ann Diagn Pathol. 2019;43:151403.
  • Galeano-Valle F, Díaz-Crespo FJ, Melero-Martín R, et al. Massive generalized crystal-storing histiocytosis associated with extracellular crystalline nephropathy: clinical, immunohistochemical, and ultrastructural studies of a unique disorder and review of the literature. CEN Case Rep. 2019;8(3):166–172.
  • Wu CK, Yang AH, Lai HC, et al. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma. BMC Nephrol. 2017;18(1):170.
  • El Hamel C, Thierry A, Trouillas P, et al. Crystal-storing histiocytosis with renal Fanconi syndrome: pathological and molecular characteristics compared with classical myeloma-associated Fanconi syndrome. Nephrol Dial Transplant. 2010;25(9):2982–2990.
  • Duquesne A, Werbrouck A, Fabiani B, et al. Complete remission of monoclonal gammopathy with ocular and periorbital crystal storing histiocytosis and Fanconi syndrome. Hum Pathol. 2013;44(5):927–933.
  • Ungari M, Ghiringhelli P, Marchi G, et al. Combined renal proximal tubulopathy and crystal storing histiocytosis in a patient with κ light chain multiple myeloma. Pathologica. 2021;113(4):285–293.
  • Sethi S, Cuiffo BP, Pinkus GS, et al. Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am J Kidney Dis. 2002;39(1):183–188.
  • Pitman SD, Wang J, Serros ER, et al. A 70-year-old woman with acute renal failure. Crystal-storing histiocytosis. Arch Pathol Lab Med. 2006;130(7):1077–1078.
  • Farooq U, Bayerl MG, Abendroth CS, et al. Renal crystal storing histiocytosis in a patient with multiple myeloma. Ann Hematol. 2009;88(8):807–809.
  • Aline-Fardin A, Bender S, Fabiani B, et al. Pseudo-peritoneal carcinomatosis presentation of a crystal-storing histiocytosis with an unmutated monoclonal κ light chain. Medicine. 2015;94(32):e1247.
  • Keane C, Gill D. Multi-organ involvement with crystal-storing histiocytosis. Br J Haematol. 2008;141(6):750.
  • Stokes MB, Aronoff B, Siegel D, et al. Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis. Kidney Int. 2006;70(3):597–602.
  • Weichman K, Dember LM, Prokaeva T, et al. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant. 2006;38(5):339–343.
  • Tholouli E, Krebs M, Reeve R, et al. Crystal-storing histiocytosis in a patient with IgG kappa multiple myeloma. Br J Haematol. 2005;128(4):412.
  • Takahashi K, Naito M, Takatsuki K, et al. Multiple myeloma, IgA kappa type, accompanying crystal-storing histiocytosis and amyloidosis. Acta Pathol Jpn. 1987;37(1):141–154.
  • Kapadia SB, Enzinger FM, Heffner DK, et al. Crystal-storing histiocytosis associated with lymphoplasmacytic neoplasms. Report of three cases mimicking adult rhabdomyoma. Am J Surg Pathol. 1993;17(5):461–467.
  • Garc-Ia JF, Sánchez E, Lloret E, et al. Crystal-storing histiocytosis and immunocytoma associated with multifocal fibrosclerosis. Histopathology. 1998;33(5):459–464.
  • Dogan S, Barnes L, Cruz-Vetrano WP. Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification. Head Neck Pathol. 2012;6(1):111–120.
  • Reeders J, Arnold C, Chen J, et al. Crystal-storing histiocytosis leading to the identification of IgG-kappa secreting lymphoplasmacytic lymphoma with crystalline nephropathy. Pathology. 2020;52(2):283–286.
  • Matthai SM, Alexander S, Jacob S, et al. Crystals, crystals everywhere but not a clue till late… light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy. Indian J Pathol Microbiol. 2020;63(3):463–466.
  • Papla B, Spólnik P, Rzenno E, et al. Generalized crystal-storing histiocytosis as a presentation of multiple myeloma: a case with a possible pro-aggregation defect in the immunoglobulin heavy chain. Virchows Arch. 2004;445(1):83–89.
  • Nakamura Y, Kitamura H, Ikai H, et al. Combined light chain crystalline tubulopathy, podocytopathy, and histiocytosis associated with Bence-Jones κ protein diagnosed via immunoelectron microscopy. CEN Case Rep. 2021;10(3):453–458.
  • Yamamoto T, Hishida A, Honda N, et al. Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma [published correction appears in Arch Pathol Lab Med 1991 aug;115(8):806]. Arch Pathol Lab Med. 1991;115(4):351–354.
  • Ito K, Hara S, Yamada K, et al. A case report of crystalline light chain inclusion-associated kidney disease affecting podocytes but without Fanconi syndrome: a clonal analysis of pathological monoclonal light chain. Medicine. 2019;98(5):e13915.
  • Boudhabhay I, Titah C, Talbot A, et al. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: a case report. Medicine. 2018;97(52):e13638.
  • Yu XJ, Zhou XJ, Wang SX, et al. Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review. BMC Nephrol. 2018;19(1):322.
  • Luciani A, Sirac C, Terryn S, et al. Impaired lysosomal function underlies monoclonal light chain-associated renal Fanconi syndrome. J Am Soc Nephrol. 2016;27(7):2049–2061.
  • Sanders PW. Mechanisms of light chain injury along the tubular nephron. J Am Soc Nephrol. 2012;23(11):1777–1781.
  • Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, et al. Crystal-storing histiocytosis: a clinicopathological study of 13 cases. Histopathology. 2016;68(4):482–491.
  • Sirac C, Batuman V, Sanders PW. The proximal tubule toxicity of immunoglobulin light chains. Kidney Int Rep. 2021;6(5):1225–1231.
  • Bridoux F, Leung N, Hutchison CA, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698–711.
  • Nasr SH, Preddie DC, Markowitz GS, et al. Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes. Kidney Int. 2006;69(3):616–620.
  • Sathick IJ, Drosou ME, Leung N. Myeloma light chain cast nephropathy, a review. J Nephrol. 2019;32(2):189–198.
  • Jain A, Haynes R, Kothari J, et al. Pathophysiology and management of monoclonal gammopathy of renal significance. Blood Adv. 2019;3(15):2409–2423.
  • Ryan M, Rovin B, Nadasdy T. Stable long-term renal function in a patient with κ-light chain renal tubular crystalline deposition. Clin Nephrol. 2015;83(3):189–195.